MicroRNAs as potential diagnostic and prognostic biomarkers in melanoma.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  European Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.ejca.2015.10.009PMID 26693896
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Serum‐based miRNAs in the prediction and detection of recurrence in melanoma patients

  2015cited by this paper
• Non-coding RNA: Editing suppresses melanoma progression

  2015cited by this paper
• MicroRNA and cancer--a brief overview.

  2015cited by this paper
• Pro-survival role of MITF in melanoma.

  2015cited by this paper
• MiR-21 Enhances Melanoma Invasiveness via Inhibition of Tissue Inhibitor of Metalloproteinases 3 Expression: In Vivo Effects of MiR-21 Inhibitor

  2015cited by this paper
• Immune biomarkers: the promises and pitfalls of personalized medicine

  2015cited by this paper
• Genomic instability: Building bridges

  2015cited by this paper
• MicroRNA and mRNA expression profiling in metastatic melanoma reveal associations with BRAF mutation and patient prognosis

  2015cited by this paper
• Dysregulation of microRNA biogenesis and gene silencing in cancer

  2015cited by this paper
• Tumorigenesis: Order matters

  2015cited by this paper
• Combining Immunotherapy with Oncogene-Targeted Therapy: A New Road for Melanoma Treatment

  2015cited by this paper
• MicroRNA expression profiling and DNA methylation signature for deregulated microRNA in cutaneous T-cell lymphoma.

  2015cited by this paper
• MicroRNAs in cancer.

  2014cited by this paper
• Novel and enhanced anti-melanoma DNA vaccine targeting the tyrosinase protein inhibits myeloid-derived suppressor cells and tumor growth in a syngeneic prophylactic and therapeutic murine model

  2014cited by this paper
• ERBB3 is required for metastasis formation of melanoma cells

  2014cited by this paper
• Transcription factor/microRNA axis blocks melanoma invasion program by miR-211 targeting NUAK1.

  2014cited by this paper
• MicroRNA-203 regulates melanosome transport and tyrosinase expression in melanoma cells by targeting kinesin superfamily protein 5b.

  2014cited by this paper
• MicroRNA-340 as a modulator of RAS-RAF-MAPK signaling in melanoma.

  2014cited by this paper
• miRNA Regulation of Programmed Cell Death-1 in T Cells: Potential Prognostic and Therapeutic Markers in Melanoma

  2014cited by this paper
• Biomarkers in melanoma: where are we now?

  2014cited by this paper
• Dysregulation of BMI1 and microRNA-16 collaborate to enhance an anti-apoptotic potential in the side population of refractory mantle cell lymphoma

  2014cited by this paper
• MicroRNA‐mediated regulation of melanoma

  2014cited by this paper
• Clinical relevance of circulating cell-free microRNAs in cancer

  2014cited by this paper
• Circulating immune cell and microRNA in patients with uveal melanoma developing metastatic disease.

  2014cited by this paper
• The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma.

  2014cited by this paper
• Downregulation of miR-140 promotes cancer stem cell formation in basal-like early stage breast cancer

  2014cited by this paper
• MicroRNAs in cancer: biomarkers, functions and therapy.

  2014cited by this paper
• miR-211 Modulates Gemcitabine Activity Through Downregulation of Ribonucleotide Reductase and Inhibits the Invasive Behavior of Pancreatic Cancer Cells

  2014cited by this paper
• MicroRNA Expression Patterns Related to Merkel Cell Polyomavirus Infection in Human Merkel Cell Carcinoma

  2013cited by this paper
• [Target prediction and verification of miR-27a in pancreatic cancer].

  2013cited by this paper
• miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes.

  2013cited by this paper
• Molecular mechanisms underlying the role of microRNAs in resistance to epidermal growth factor receptor-targeted agents and novel therapeutic strategies for treatment of non-small-cell lung cancer.

  2013cited by this paper
• Intercellular Communication by Exosome-Derived microRNAs in Cancer

  2013cited by this paper
• New Target Genes of MITF-Induced microRNA-211 Contribute to Melanoma Cell Invasion

  2013cited by this paper
• [Expression of microRNA-100 in human gastric cancer].

  2013cited by this paper
• Clinical Applications for microRNAs in Cancer

  2013cited by this paper
• Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma

  2013cited by this paper
• Ras, Raf, and MAP Kinase in Melanoma

  2013cited by this paper
• Potential biomarkers for malignant melanoma

  2013cited by this paper
• The Role of miR-18b in MDM2-p53 Pathway Signaling and Melanoma Progression

  2013cited by this paper
• Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009

  2013cited by this paper
• miR-126&126* Restored Expressions Play a Tumor Suppressor Role by Directly Regulating ADAM9 and MMP7 in Melanoma

  2013cited by this paper
• miR-573 regulates melanoma progression by targeting the melanoma cell adhesion molecule.

  2013cited by this paper
• Cancer Facts & Figures 2012. American Cancer Society (ACS)

  2012cited by this paper
• Convergent multi-miRNA targeting of ApoE drives LRP1/LRP8-dependent melanoma metastasis and angiogenesis.

  2012cited by this paper
• The hallmarks of cancer

  2012cited by this paper
• A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth

  2012cited by this paper
• Exosomal miRNAs: Biological Properties and Therapeutic Potential

  2012cited by this paper
• The proto-oncogene Pim-1 is a target of miR-33a

  2012cited by this paper
• Differential expression of microRNAs during melanoma progression: miR-200c, miR-205 and miR-211 are downregulated in melanoma and act as tumour suppressors

  2012cited by this paper
• Genetic and epigenetic loss of microRNA-31 leads to feed-forward expression of EZH2 in melanoma

  2012cited by this paper
• Serum microRNAs as biomarkers for recurrence in melanoma

  2012cited by this paper
• MicroRNA and cutaneous melanoma: from discovery to prognosis and therapy.

  2012cited by this paper
• Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

  2012cited by this paper
• MicroRNA-26a is Strongly Down-regulated in Melanoma and Induces Cell Death through Repression of Silencer of Death Domains (SODD)

  2012cited by this paper
• Identifying mRNA, MicroRNA and Protein Profiles of Melanoma Exosomes

  2012cited by this paper
• MiR-200b and miR-15b regulate chemotherapy-induced epithelial-mesenchymal transition in human tongue cancer cells by targeting BMI1

  2012cited by this paper
• Mir-33 regulates cell proliferation and cell cycle progression

  2012cited by this paper
• MicroRNA‐9 up‐regulates E‐cadherin through inhibition of NF‐κB1–Snail1 pathway in melanoma

  2012cited by this paper
• Tumour‐secreted miR‐9 promotes endothelial cell migration and angiogenesis by activating the JAK‐STAT pathway

  2012cited by this paper
• Anti-oncogenic MicroRNA-203 Induces Senescence by Targeting E2F3 Protein in Human Melanoma Cells

  2012cited by this paper
• microRNA‐214 contributes to melanoma tumour progression through suppression of TFAP2C

  2011cited by this paper
• Hallmarks of cancer: the next generation.

  2011cited by this paper
• MicroRNAs miR-199a-5p and -3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers.

  2011cited by this paper
• The circulating microRNA-221 level in patients with malignant melanoma as a new tumor marker.

  2011cited by this paper
• miR-30b/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis.

  2011cited by this paper
• Constitutive activation of the ETS-1-miR-222 circuitry in metastatic melanoma

  2011cited by this paper
• Modulation of microRNA expression in human T-cell development: targeting of NOTCH3 by miR-150.

  2011cited by this paper
• MicroRNA-137 Targets Carboxyl-terminal Binding Protein 1 in Melanoma Cell Lines

  2011cited by this paper
• Let-7b-mediated suppression of basigin expression and metastasis in mouse melanoma cells.

  2011cited by this paper
• MicroRNA-149*, a p53-responsive microRNA, functions as an oncogenic regulator in human melanoma

  2011cited by this paper
• miR-193b Regulates Mcl-1 in Melanoma.

  2011cited by this paper
• Downregulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcome in cutaneous melanoma

  2011cited by this paper
• miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein*

  2011cited by this paper
• Efficient in vivo microRNA targeting of liver metastasis

  2011cited by this paper
• MicroRNA miR-21 Regulates the Metastatic Behavior of B16 Melanoma Cells*

  2011cited by this paper
• Epigenetic Regulation of MicroRNA Genes and the Role of miR-34b in Cell Invasion and Motility in Human Melanoma

  2011cited by this paper
• KIT as a therapeutic target in metastatic melanoma.

  2011cited by this paper
• Sustained inhibition of PKCα reduces intravasation and lung seeding during mammary tumor metastasis in an in vivo mouse model

  2010cited by this paper
• MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2.

  2010cited by this paper
• High-throughput miRNA profiling of human melanoma blood samples

  2010cited by this paper
• MicroRNA-340-mediated Degradation of Microphthalmia-associated Transcription Factor mRNA Is Inhibited by the Coding Region Determinant-binding Protein*

  2010cited by this paper
• MicroRNA-200 Family Members Differentially Regulate Morphological Plasticity and Mode of Melanoma Cell Invasion

  2010cited by this paper
• miR-148 Regulates Mitf in Melanoma Cells

  2010cited by this paper
• A MicroRNA Screen to Identify Modulators of Sensitivity to BCL2 Inhibitor ABT-263 (Navitoclax)

  2010cited by this paper
• Melanoma MicroRNA Signature Predicts Post-Recurrence Survival

  2010cited by this paper
• Tumorigenesis and Neoplastic Progression MicroRNA-193b Represses Cell Proliferation and Regulates Cyclin D1 in Melanoma

  2010cited by this paper
• MicroRNA‐15b represents an independent prognostic parameter and is correlated with tumor cell proliferation and apoptosis in malignant melanoma

  2010cited by this paper
• MicroRNA-dependent regulation of cKit in cutaneous melanoma.

  2009cited by this paper
• Altered expression of selected microRNAs in melanoma: antiproliferative and proapoptotic activity of miRNA-155.

  2009cited by this paper
• MicroRNAs in Cancer.

  2009cited by this paper
• Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor

  2009cited by this paper
• MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.

  2009cited by this paper
• miRNA expression profiling in melanocytes and melanoma cell lines reveals miRNAs associated with formation and progression of malignant melanoma.

  2009cited by this paper
• p53 represses c-Myc through induction of the tumor suppressor miR-145

  2009cited by this paper
• Regulation of RUNX3 Tumor Suppressor Gene Expression in Cutaneous Melanoma

  2009cited by this paper
• MicroRNA regulation of DNA repair gene expression in hypoxic stress.

  2009cited by this paper
• An Integrated Approach for Experimental Target Identification of Hypoxia-induced miR-210*

  2009cited by this paper
• MicroRNA let-7b targets important cell cycle molecules in malignant melanoma cells and interferes with anchorage-independent growth

  2008cited by this paper
• MicroRNA-210 Modulates Endothelial Cell Response to Hypoxia and Inhibits the Receptor Tyrosine Kinase Ligand Ephrin-A3*

  2008cited by this paper

• Harnessing the connection of the Wnt/beta-catenin pathway and other signaling pathways in glioblastoma multiforme.

  2026cites this paper
• Uncovering molecular signatures and pathogenic pathways in myotonic dystrophy type 1 through bioinformatic analysis

  2026cites this paper
• Spatiotemporal fluorescence imaging of microRNA activity in 3-D models of human epidermis reveals contribution of the Notch pathway in the regulation of miR-30a in aging skin

  2025cites this paper
• Pyroptosis in cancer therapy: a double-edged sword for immune activation and tumor progression

  2025cites this paper
• Extracellular Vesicles in Skin: Biological Function and Therapeutic Potential

  2025cites this paper
• Repurposing ivermectin: a new hope for glioblastoma multiforme?

  2025cites this paper
• Long non-coding RNA CYTOR promotes the progression of melanoma via the miR-485-5p/GPI axis

  2025cites this paper
• SOX10, MITF, and microRNAs: Decoding their interplay in regulating melanoma plasticity

  2025cites this paper
• Harnessing the role of insulin-like growth factor in glioblastoma: a comprehensive review.

  2025cites this paper
• Molecular and Clinicopathological Biomarkers in the Neoadjuvant Treatment of Patients with Advanced Resectable Melanoma

  2024cites this paper
• A New Approach to Melanoma Treatment: microRNAs.

  2024cites this paper
• Gestational Diabetes Mellitus and its Effects on the Developing Cerebellum: A Narrative Review on Experimental Studies

  2024cites this paper
• Contemporary views on the clinical, epidemiological and molecular genetic characteristics of melanoma of the skin and mucous membranes

  2024cites this paper
• Upregulation and functional roles of miR-450b in canine oral melanoma

  2024cites this paper
• The key role of microRNA-766 in the cancer development

  2023cites this paper
• Investigating the tumor-immune microenvironment through extracellular vesicles from frozen patient biopsies and 3D cultures

  2023cites this paper
• Blood-based microRNAs as Potential Diagnostic biomarkers for Melanoma: A Meta-analysis.

  2023cites this paper
• Prostate cancer and microRNAs: New insights into apoptosis.

  2023cites this paper
• Current Trends in Circulating Biomarkers for Melanoma Detection

  2022cites this paper
• Where Microneedle Meets Biomarkers: Futuristic Application for Diagnosing and Monitoring Localized External Organ Diseases

  2022cites this paper
• Identification of a miRNA-based non-invasive predictive biomarker of response to target therapy in BRAF-mutant melanoma

  2022cites this paper
• Prognostic Value of IGF2 mRNA-Binding Protein 3 (IGF2BP3) Intratumoral Expression in Melanoma Patients at the Time of Diagnosis: Comparative Analysis of RT-qPCR Versus Immunohistochemistry

  2022cites this paper
• The Prognostic Value of miR-125b, miR-200c and miR-205 in Primary Cutaneous Malignant Melanoma Is Independent of BRAF Mutational Status

  2022cites this paper
• Predicting the possible effect of miR-203a-3p and miR-29a-3p on DNMT3B and GAS7 genes expression

  2021influential citation
• The prediction and expression of miR-203a-p and miR-29b* against DNMT3B as well as TNFAIP3 in melanoma

  2021cites this paper
• Skin Cancer: Molecular Biomarker for Diagnosis, Prognosis, Prevention, and Targeted Therapy

  2021cites this paper
• Vitiligo-specific soluble biomarkers as early indicators of response to immune checkpoint inhibitors in metastatic melanoma patients

  2021cites this paper
• Exosomes: Emerging Cell-Free Based Therapeutics in Dermatologic Diseases

  2021cites this paper
• Noncoding Gene Families of the Human Genome

  2021cites this paper
• Comprehensive Analysis of Differentially Expressed lncRNAs miRNAs and mRNA and Their ceRNA Network of Patients With Rare-Earth Pneumoconiosis

  2021cites this paper
• Identification of melanoma‐specific exosomal miRNAs as the potential biomarker for canine oral melanoma

  2021cites this paper
• Circ_0013359 facilitates the tumorigenicity of melanoma by regulating miR-136-5p/RAB9A axis

  2021cites this paper
• Circular RNA circ_0079593 enhances malignant melanoma progression by the regulation of the miR-573/ABHD2 axis.

  2021cites this paper
• Tumor suppressive microRNA‐485‐5p targets PRRX1 in human skin melanoma cells, regulating epithelial–mesenchymal transition and apoptosis

  2021cites this paper
• Exosomal microRNAs in cancer-related sarcopenia: Tumor-derived exosomal microRNAs in muscle atrophy

  2021cites this paper
• Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis

  2020cites this paper
• RETRACTED ARTICLE: microRNA-192-5p is involved in nerve repair in rats with peripheral nerve injury by regulating XIAP

  2020cites this paper
• Extracellular genetic materials and their application in clinical practice.

  2020cites this paper
• Nuclear factor I/B mediates epithelial-mesenchymal transition in human melanoma cells through ZEB1

  2020cites this paper
• The diagnostic, prognostic and therapeutic potential of circulating microRNAs in ovarian cancer.

  2020cites this paper
• MicroRNAs at the Crossroad of the Dichotomic Pathway Cell Death vs. Stemness in Neural Somatic and Cancer Stem Cells: Implications and Therapeutic Strategies

  2020cites this paper
• A HPV16-related prognostic indicator for head and neck squamous cell carcinoma

  2020cites this paper
• Paraoxonase-2 Silencing Enhances Sensitivity of A375 Melanoma Cells to Treatment with Cisplatin

  2020cites this paper
• miR-371b-5p promotes cell proliferation, migration and invasion in non-small cell lung cancer via SCAI

  2020cites this paper
• Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in skin cutaneous melanoma

  2020cites this paper
• MicroRNA-214 promotes the EMT process in melanoma by downregulating CADM1 expression

  2020cites this paper
• Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging techniques.

  2020cites this paper
• MicroRNA-21-Enriched Exosomes as Epigenetic Regulators in Melanomagenesis and Melanoma Progression: The Impact of Western Lifestyle Factors

  2020cites this paper
• Role of non-coding RNAs in the progression and resistance of cutaneous malignancies and autoimmune diseases.

  2020cites this paper
• Vitamin D and non-coding RNAs: new insights into the regulation of breast cancer.

  2020cites this paper
• MicroRNAs as Key Players in Melanoma Cell Resistance to MAPK and Immune Checkpoint Inhibitors

  2020cites this paper
• microRNA in inflammatory bowel disease at a glance.

  2020cites this paper
• Modulation of microRNAs by aspirin in cardiovascular disease.

  2020cites this paper
• Distinguishing Tumor and Stromal Sources of MicroRNAs Linked to Metastasis in Cutaneous Melanoma

  2020cites this paper
• The differential expression of micro-RNAs 21, 200c, 204, 205, and 211 in benign, dysplastic and malignant melanocytic lesions and critical evaluation of their role as diagnostic biomarkers

  2020cites this paper
• miR-140-3p Inhibits Cutaneous Melanoma Progression by Disrupting AKT/p70S6K and JNK Pathways through ABHD2

  2020cites this paper
• Casticin inhibits stemness of hepatocellular carcinoma cells via disrupting the reciprocal negative regulation between DNMT1 and miR-148a-3p.

  2020cites this paper
• Reconstruction of lncRNA-miRNA-mRNA network based on competitive endogenous RNA reveals functional lncRNAs in melanoma

  2020cites this paper
• Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma

  2020cites this paper
• Anti-angiogenic role of microRNA-23b in melanoma by disturbing NF-κB signaling pathway via targeted inhibition of NAMPT.

  2020cites this paper
• miRNAs in the Diagnosis and Prognosis of Skin Cancer

  2020cites this paper
• microRNA-378a-5p iS a novel positive regulator of melanoma progression

  2020cites this paper
• Silencing of microRNA-517a induces oxidative stress injury in melanoma cells via inactivation of the JNK signaling pathway by upregulating CDKN1C

  2020cites this paper
• Circular RNA ITCH: A novel tumor suppressor in multiple cancers.

  2019cites this paper
• miR-150 Suppresses Tumor Growth in Melanoma Through Downregulation of MYB.

  2019cites this paper
• Circulating cell‐free microRNAs in cutaneous melanoma staging and recurrence or survival prognosis

  2019influential citation
• EGFL7 silencing inactivates the Notch signaling pathway; enhancing cell apoptosis and suppressing cell proliferation in human cutaneous melanoma.

  2019cites this paper
• MicroRNA and exosome: Key players in rheumatoid arthritis

  2019cites this paper
• PPAR‐γ: Its ligand and its regulation by microRNAs

  2019cites this paper
• Role of miRNAs in Melanoma Metastasis

  2019cites this paper
• Melanomics: Comprehensive Molecular Analysis of Normal and Neoplastic Melanocytes

  2019cites this paper
• Prognostic value of long non-coding RNA ZEB1-AS1 in Chinese cancer patients

  2019cites this paper
• Pancreatic β‐cell regeneration: From molecular mechanisms to therapy

  2019cites this paper
• MicroRNAs and response to therapy in leukemia

  2019cites this paper
• Melanoma-Derived Extracellular Vesicles: Focus on Their Proteome

  2019cites this paper
• Prognostic value of long noncoding RNA ROR in patients with cancer in China

  2019cites this paper
• MicroRNA heterogeneity in melanoma progression.

  2019cites this paper
• Exosomal microRNA and stroke: A review

  2019cites this paper
• MicroRNA‐329 upregulation impairs the HMGB2/β‐catenin pathway and regulates cell biological behaviors in melanoma

  2019cites this paper
• Expression Profiles of miR-93 and miR-330 in Iranian Patients with Chronic Lymphocytic Leukemia

  2019cites this paper
• Exosomes: diagnostic biomarkers and therapeutic delivery vehicles for cancer.

  2019cites this paper
• Overexpression of microRNA-21 inhibits the growth and metastasis of melanoma cells by targeting MKK3

  2019cites this paper
• Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in prostate cancer: Current status and future perspectives

  2019cites this paper
• Functional and Molecular Role of Processed-Beverages Toward Healthier Lifestyle

  2019cites this paper
• A preliminary study of microRNA expression in different types of primary melanoma

  2019cites this paper
• Circulating microRNA expression profiling and bioinformatics analysis of patients with coronary artery disease by RNA sequencing

  2019cites this paper
• 1 Micro RNA transcriptome profile in canine oral 2 melanoma 3

  2019cites this paper
• Pathogenic role of exosomes and microRNAs in HPV‐mediated inflammation and cervical cancer: A review

  2019cites this paper
• Micro RNA Transcriptome Profile in Canine Oral Melanoma

  2019cites this paper
• Cancer stem cells as therapeutic targets of pancreatic cancer

  2019cites this paper
• Prognostic and clinical significance of long non-coding RNA HNF1A-AS1 in solid cancers

  2019cites this paper
• Mir-5100 Mediates Proliferation, Migration and Invasion of Oral Squamous Cell Carcinoma Cells Via Targeting SCAI

  2019cites this paper
• MicroRNAs in Melanoma Resistance to Mitogen-Activated Protein Kinase Pathway Inhibitors

  2019cites this paper
• Molecular aspects of pancreatic β‐cell dysfunction: Oxidative stress, microRNA, and long noncoding RNA

  2018cites this paper
• GD2‐targeted immunotherapy and potential value of circulating microRNAs in neuroblastoma

  2018cites this paper
• Liquid Biopsy zur Überwachung von Melanompatienten

  2018cites this paper
• MicroRNAs and exosomes in depression: Potential diagnostic biomarkers

  2018cites this paper
• Circulating Exosomal miR-20b-5p Is Elevated in Type 2 Diabetes and Could Impair Insulin Action in Human Skeletal Muscle

  2018cites this paper
• State of the art in microRNA as diagnostic and therapeutic biomarkers in chronic lymphocytic leukemia

  2018influential citation
• Melanoma: Where we are and where we go

  2018cites this paper